Autonomix Medical Inc (AMIX)

$3.14 +0.28 (9.79%)
Market Cap 3.30M
Revenue (ttm) 0.00
Net Income (ttm) -15.43M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.36
Volume 4,300,900
Avg Vol 497,016
Day's Range N/A - N/A
Shares Out 1.15M
Stochastic %K 58%
Beta N/A
Analysts Strong Sell
Price Target $28.00

Latest News on AMIX

Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Jan 17, 2025, 8:00 AM EST - 19 hours ago

Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

Jan 15, 2025, 8:30 AM EST - 2 days ago

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

Autonomix Medical, Inc. Announces Abstract Highlighting Preliminary Positive Clinical Results Accepted at The Society of Interventional Oncology (SIO) 2025 Annual Scientific Meeting

Jan 13, 2025, 8:30 AM EST - 4 days ago

Autonomix Medical, Inc. Announces Abstract Highlighting Preliminary Positive Clinical Results Accepted at The Society of Interventional Oncology (SIO) 2025 Annual Scientific Meeting

Autonomix Medical, Inc. Announces U.S. Patent Granted Covering the Treatment of Cancerous Tumors and Cancer Related Pain with Company's Proprietary Catheter-Based Technology

Dec 30, 2024, 8:30 AM EST - 18 days ago

Autonomix Medical, Inc. Announces U.S. Patent Granted Covering the Treatment of Cancerous Tumors and Cancer Related Pain with Company's Proprietary Catheter-Based Technology

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

Dec 23, 2024, 8:30 AM EST - 25 days ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Dec 5, 2024, 8:30 AM EST - 6 weeks ago

Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option

Nov 25, 2024, 4:00 PM EST - 7 weeks ago

Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option

Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering

Nov 22, 2024, 9:15 AM EST - 2 months ago

Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering

Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Nov 11, 2024, 8:00 AM EST - 2 months ago

Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Autonomix Medical, Inc.'s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial

Oct 30, 2024, 8:30 AM EDT - 2 months ago

Autonomix Medical, Inc.'s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial

Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher

Oct 28, 2024, 12:06 PM EDT - 2 months ago

Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher

Why Is Nao-Cap Neurology Focused Autonomix Medical Stock Trading Higher On Monday?

Oct 28, 2024, 11:08 AM EDT - 2 months ago

Why Is Nao-Cap Neurology Focused Autonomix Medical Stock Trading Higher On Monday?

Autonomix Medical, Inc. to Participate in a Virtual Investor “What This Means” Segment on Wednesday, October 30th

Oct 25, 2024, 11:30 AM EDT - 3 months ago

Autonomix Medical, Inc. to Participate in a Virtual Investor “What This Means” Segment on Wednesday, October 30th

Autonomix Announces Reverse Stock Split

Oct 22, 2024, 8:30 AM EDT - 3 months ago

Autonomix Announces Reverse Stock Split

Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC

Oct 8, 2024, 8:30 AM EDT - 3 months ago

Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC

Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum

Sep 20, 2024, 8:30 AM EDT - 4 months ago

Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum

Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference

Aug 27, 2024, 8:30 AM EDT - 5 months ago

Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference

Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress

Aug 21, 2024, 8:30 AM EDT - 5 months ago

Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress

Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones

Aug 13, 2024, 8:00 AM EDT - 5 months ago

Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Covering Technology License Agreement

Jul 18, 2024, 8:30 AM EDT - 6 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Covering Technology License Agreement

Autonomix Medical, Inc. (NASDAQ: AMIX) Reviews Positive Results Seen in Pancreatic Cancer Pain Trial in Virtual Investor “What This Means” Segment

Jul 3, 2024, 9:00 AM EDT - 7 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Reviews Positive Results Seen in Pancreatic Cancer Pain Trial in Virtual Investor “What This Means” Segment

Autonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, Brad Hauser, as President and Chief Executive Officer

Jun 17, 2024, 4:05 PM EDT - 7 months ago

Autonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, Brad Hauser, as President and Chief Executive Officer

Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial

Jun 3, 2024, 8:15 AM EDT - 8 months ago

Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial

Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update

May 31, 2024, 8:05 AM EDT - 8 months ago

Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update

Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer

May 23, 2024, 9:15 AM EDT - 8 months ago

Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer

Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

Apr 24, 2024, 9:00 AM EDT - 9 months ago

Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain

Apr 16, 2024, 9:00 AM EDT - 9 months ago

Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain

Autonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation

Apr 9, 2024, 8:30 AM EDT - 10 months ago

Autonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation

Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker

Apr 8, 2024, 8:30 AM EDT - 10 months ago

Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker

Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference

Mar 27, 2024, 9:00 AM EDT - 10 months ago

Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference

Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024

Mar 20, 2024, 8:05 AM EDT - 10 months ago

Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024

Autonomix Appoints Jennifer Cook as Chief Business Officer

Mar 19, 2024, 8:45 AM EDT - 10 months ago

Autonomix Appoints Jennifer Cook as Chief Business Officer

Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

Mar 14, 2024, 8:15 AM EDT - 11 months ago

Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

Autonomix Enrolls First Patients in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

Mar 6, 2024, 8:00 AM EST - 11 months ago

Autonomix Enrolls First Patients in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

Autonomix Signs Key Clinical Agreements in Preparation to Begin March 2024 Human Clinical Trial

Feb 29, 2024, 8:30 AM EST - 11 months ago

Autonomix Signs Key Clinical Agreements in Preparation to Begin March 2024 Human Clinical Trial

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break: The Autonomix Opportunity

Feb 23, 2024, 8:50 AM EST - 11 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break: The Autonomix Opportunity

Autonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

Feb 16, 2024, 8:00 AM EST - 1 year ago

Autonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

Autonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key Milestones

Feb 14, 2024, 8:05 AM EST - 1 year ago

Autonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key Milestones

Autonomix Medical, Inc. (NASDAQ:AMIX) to Present at Integrous Big Hearts, Big Ideas Virtual Investor Conference

Feb 9, 2024, 8:45 AM EST - 1 year ago

Autonomix Medical, Inc. (NASDAQ:AMIX) to Present at Integrous Big Hearts, Big Ideas Virtual Investor Conference

Autonomix Medical, Inc. Receives Ethics Committee Authorization for Proof-of-Concept Human Clinical Study Evaluating Proprietary Ablation Technology for Treatment of Pancreatic Cancer Pain

Feb 6, 2024, 8:50 AM EST - 1 year ago

Autonomix Medical, Inc. Receives Ethics Committee Authorization for Proof-of-Concept Human Clinical Study Evaluating Proprietary Ablation Technology for Treatment of Pancreatic Cancer Pain

Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the Virtual Investor New to the Street Event

Feb 1, 2024, 8:35 AM EST - 1 year ago

Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the Virtual Investor New to the Street Event

Autonomix Medical, Inc. to Ring the Nasdaq Stock Market Closing Bell on Thursday, February 1, 2024

Jan 31, 2024, 8:45 AM EST - 1 year ago

Autonomix Medical, Inc. to Ring the Nasdaq Stock Market Closing Bell on Thursday, February 1, 2024

Autonomix Medical, Inc. Completes $8,000,000 Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use – Over 100 patents in portfolio

Jan 30, 2024, 12:00 PM EST - 1 year ago

Autonomix Medical, Inc. Completes $8,000,000 Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use – Over 100 patents in portfolio

Autonomix Medical, Inc. Completes Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use

Jan 30, 2024, 9:05 AM EST - 1 year ago

Autonomix Medical, Inc. Completes Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use

Autonomix Medical, Inc. (NASDAQ: AMIX) Commences Trading on NASDAQ

Jan 29, 2024, 8:05 AM EST - 1 year ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Commences Trading on NASDAQ

Autonomix Medical, Inc. Announces Closing of $11.2 Million in Gross Proceeds from Initial Public Offering

Jan 26, 2024, 4:05 PM EST - 1 year ago

Autonomix Medical, Inc. Announces Closing of $11.2 Million in Gross Proceeds from Initial Public Offering